Notch signaling in the malignant bone marrow microenvironment: Implications for a niche-based model of oncogenesis

Annals of the New York Academy of Sciences

Volumn 1335, Issue 1, 2015, Pages 63-77

  Evans, Andrew G ^a   Calvi, Laura M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Bone marrow; Delta; Hematopoiesis; HSC; Jagged; Leukemia; Malignancy; Microenvironment; Notch; Stem cell

Indexed keywords

MUS MUSCULUS;

NOTCH RECEPTOR;

ANIMAL; BONE MARROW; BONE MARROW CANCER; CARCINOGENESIS; CELL TRANSFORMATION; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANIMALS; BONE MARROW; BONE MARROW NEOPLASMS; CARCINOGENESIS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84920419095     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12562     Document Type: Review

References (126)

1. Calvi, L.M. & D.C. Link . 2014. Cellular complexity of the bone marrow hematopoietic stem cell niche. Calcif. Tissue Int. 94: 112-124.
2. Morrison, S.J. & D.T. Scadden . 2014. The bone marrow niche for haematopoietic stem cells. Nature 505: 327-334.
3. Lo Celso, C., C.P. Lin & D.T. Scadden . 2011. In vivo imaging of transplanted hematopoietic stem and progenitor cells in mouse calvarium bone marrow. Nat. Protoc. 6: 1-14.
4. Walter, R.B., F.R. Appelbaum, E.H. Estey, et al. 2012. Acute myeloid leukemia stem cells and CD33-targeted immunotherapy. Blood 119: 6198-6208.
5. Wang, L., H. O'Leary, J. Fortney, et al. 2007. Ph+/VE-cadherin + identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells. Blood 110: 3334-3344.
6. Bhatia, M., J.C. Wang, U. Kapp, et al. 1997. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94: 5320-5325.
7. Bonnet, D. & J.E. Dick . 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3: 730-737.
8. Lapidot, T., C. Sirard, J. Vormoor, et al. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
9. Pang, W.W., J.V. Pluvinage, E.A. Price, et al. 2013. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc. Natl. Acad. Sci. U. S. A. 110: 3011-3016.
10. Weigert, O., N. Kopp, A.A. Lane, et al. 2012. Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Cancer. Discov. 2: 47-55.
11. Martinez-Climent, J.A., L. Fontan, R.D. Gascoyne, et al. 2010. Lymphoma stem cells: enough evidence to support their existence? Haematologica 95: 293-302.
12. Chen, Z., P. Ayala, M. Wang, et al. 2010. Prospective isolation of clonogenic mantle cell lymphoma-initiating cells. Stem Cell. Res. 5: 212-225.
13. Penton, A.L., L.D. Leonard & N.B. Spinner . 2012. Notch signaling in human development and disease. Semin. Cell Dev. Biol. 23: 450-457.
14. Aster, J.C., S.C. Blacklow & W.S. Pear . 2011. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J. Pathol. 223: 262-273.
15. Wharton, K.A., K.M. Johansen, T. Xu, et al. 1985. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 43: 567-581.
16. Kidd, S., M.R. Kelley & M.W. Young . 1986. Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors. Mol. Cell. Biol. 6: 3094-3108.
17. Artavanis-Tsakonas, S., M.D. Rand & R.J. Lake . 1999. Notch signaling: cell fate control and signal integration in development. Science 284: 770-776.
18. D'Souza, B., A. Miyamoto & G. Weinmaster . 2008. The many facets of Notch ligands. Oncogene 27: 5148-5167.
19. D'Souza, B., L. Meloty-Kapella & G. Weinmaster . 2010. Canonical and non-canonical Notch ligands. Curr. Top. Dev. Biol. 92: 73-129.
20. Andersen, P., H. Uosaki, L.T. Shenje, et al. 2012. Non-canonical Notch signaling: emerging role and mechanism. Trends Cell Biol. 22: 257-265.
21. Capaccione, K.M. & S.R. Pine . 2013. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 34: 1420-1430.
22. Hori, K., A. Sen & S. Artavanis-Tsakonas . 2013. Notch signaling at a glance. J. Cell. Sci. 126: 2135-2140.
23. Kandachar, V. & F. Roegiers . 2012. Endocytosis and control of Notch signaling. Curr. Opin. Cell Biol. 24: 534-540.
24. Chillakuri, C.R., D. Sheppard, S.M. Lea, et al. 2012. Notch receptor-ligand binding and activation: insights from molecular studies. Semin. Cell Dev. Biol. 23: 421-428.
25. Musse, A.A., L. Meloty-Kapella & G. Weinmaster . 2012. Notch ligand endocytosis: mechanistic basis of signaling activity. Semin. Cell Dev. Biol. 23: 429-436.
26. Ramasamy, S.K., A.P. Kusumbe, L. Wang, et al. 2014. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507: 376-380.
27. Engin, F., Z. Yao, T. Yang, et al. 2008. Dimorphic effects of Notch signaling in bone homeostasis. Nat. Med. 14: 299-305.
28. Hilton, M.J., X. Tu, X. Wu, et al. 2008. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 14: 306-314.
29. + hematopoietic precursors. Blood 83: 2057-2062.
30. Kim, J.A., Y.J. Kang, G. Park, et al. 2009. Identification of a stroma-mediated Wnt/β-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche. Stem Cells 27: 1318-1329.
31. Hosokawa, K., F. Arai, H. Yoshihara, et al. 2010. Cadherin-based adhesion is a potential target for niche manipulation to protect hematopoietic stem cells in adult bone marrow. Cell Stem Cell 6: 194-198.
32. Hosokawa, K., F. Arai, H. Yoshihara, et al. 2010. Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells. Blood 116: 554-563.
33. Arai, F., A. Hirao, M. Ohmura, et al. 2004. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118: 149-161.
34. Nilsson, S.K., H.M. Johnston, G.A. Whitty, et al. 2005. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106: 1232-1239.
35. Stier, S., Y. Ko, R. Forkert, et al. 2005. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201: 1781-1791.
36. Ellisen, L.W., J. Bird, D.C. West, et al. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66: 649-661.
37. Weng, A.P., A.A. Ferrando, W. Lee, et al. 2004. Activating mutations of Notch1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271.
38. Jundt, F., R. Schwarzer & B. Dorken . 2008. Notch signaling in leukemias and lymphomas. Curr. Mol. Med. 8: 51-59.
39. Koch, U. & F. Radtke . 2010. Notch signaling in solid tumors. Curr. Top. Dev. Biol. 92: 411-455.
40. Puente, X.S., M. Pinyol, V. Quesada, et al. 2011. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475: 101-105.
41. Knoechel, B., J.E. Roderick, K.E. Williamson, et al. 2014. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat. Genet. 46: 364-370.
42. Klinakis, A., C. Lobry, O. Abdel-Wahab, et al. 2011. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473: 230-233.
43. Lobry, C., P. Oh & I. Aifantis . 2011. Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J. Exp. Med. 208: 1931-1935.
44. Lobry, C., P. Oh, M.R. Mansour, et al. 2014. Notch signaling: switching an oncogene to a tumor suppressor. Blood 123: 2451-2459.
45. South, A.P., R.J. Cho & J.C. Aster . 2012. The double-edged sword of Notch signaling in cancer. Semin. Cell Dev. Biol. 23: 458-464.
46. Majeti, R., C.Y. Park & I.L. Weissman . 2007. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord Blood. Cell Stem Cell 1: 635-645.
47. Anjos-Afonso, F., E. Currie, H.G. Palmer, et al. 2013. CD34(-) cells at the apex of the human hematopoietic stem cell hierarchy have distinctive cellular and molecular signatures. Cell Stem Cell 13: 161-174.
48. Ohishi, K., B. Varnum-Finney & I.D. Bernstein . 2002. The notch pathway: modulation of cell fate decisions in hematopoiesis. Int. J. Hematol. 75: 449-459.
49. Weber, J.M. & L.M. Calvi . 2010. Notch signaling and the bone marrow hematopoietic stem cell niche. Bone 46: 281-285.
50. Pajcini, K.V., N.A. Speck & W.S. Pear . 2011. Notch signaling in mammalian hematopoietic stem cells. Leukemia 25: 1525-1532.
51. Li, L., L.A. Milner, Y. Deng, et al. 1998. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 8: 43-55.
52. Carlesso, N., J.C. Aster, J. Sklar, et al. 1999. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 93: 838-848.
53. Kumano, K., S. Chiba, K. Shimizu, et al. 2001. Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression. Blood 98: 3283-3289.
54. Stier, S., T. Cheng, D. Dombkowski, et al. 2002. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 99: 2369-2378.
55. Duncan, A.W., F.M. Rattis, L.N. DiMascio, et al. 2005. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Immunol. 6: 314-322.
56. Wu, M., H.Y. Kwon, F. Rattis, et al. 2007. Imaging hematopoietic precursor division in real time. Cell Stem Cell 1: 541-554.
57. Varnum-Finney, B., L. Xu, C. Brashem-Stein, et al. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6: 1278-1281.
58. Kunisato, A., S. Chiba, E. Nakagami-Yamaguchi, et al. 2003. HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. Blood 101: 1777-1783.
59. Chiang, M.Y., O. Shestova, L. Xu, et al. 2013. Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells. Blood 121: 905-917.
60. Calvi, L.M., G.B. Adams, K.W. Weibrecht, et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
61. Weber, J.M., S.R. Forsythe, C.A. Christianson, et al. 2006. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells. Bone 39: 485-493.
62. Kumano, K., S. Chiba, A. Kunisato, et al. 2003. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 18: 699-711.
63. Butler, J.M., D.J. Nolan, E.L. Vertes, et al. 2010. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6: 251-264.
64. Poulos M.G., P. Guo, N.M. Kofler, et al. 2013. Endothelial Jagged-1 is necessary for homeostatic and regenerative hematopoiesis. Cell. Rep. 4: 1022-1034.
65. Delaney, C., S. Heimfeld, C. Brashem-Stein, et al. 2010. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 16: 232-236.
66. Dahlberg, A., C. Delaney & I.D. Bernstein . 2011. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 117: 6083-6090.
67. Delaney, C., B. Varnum-Finney, K. Aoyama, et al. 2005. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 106: 2693-2699.
68. Jaleco, A.C., H. Neves, E. Hooijberg, et al. 2001. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J. Exp. Med. 194: 991-1002.
69. Koch, U., E. Fiorini, R. Benedito, et al. 2008. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J. Exp. Med. 205: 2515-2523.
70. Varnum-Finney, B., L.M. Halasz, M. Sun, et al. 2011. Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. J. Clin. Invest. 121: 1207-1216.
71. Oh, P., C. Lobry, J. Gao, et al. 2013. In vivo mapping of notch pathway activity in normal and stress hematopoiesis. Cell Stem Cell 13: 190-204.
72. Benveniste, P., P. Serra, D. Dervovic, et al. 2014. Notch signals are required for in vitro but not in vivo maintenance of human hematopoietic stem cells and delay the appearance of multipotent progenitors. Blood 123: 1167-1177.
73. Mancini, S.J., N. Mantei, A. Dumortier, et al. 2005. Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood 105: 2340-2342.
74. Maillard, I., U. Koch, A. Dumortier, et al. 2008. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2: 356-366.
75. Gerhardt, D.M., K.V. Pajcini, T. D'altri, et al. 2014. The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes Dev. 28: 576-593.
76. Schofield, R. 1978. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4: 7-25.
77. Gong, J.K. 1978. Endosteal marrow: a rich source of hematopoietic stem cells. Science 199: 1443-1445.
78. Taichman, R.S. & S.G. Emerson . 1998. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 16: 7-15.
79. Nilsson, S.K., H.M. Johnston & J.A. Coverdale . 2001. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97: 2293-2299.
80. Zhang, J., C. Niu, L. Ye, et al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836-841.
81. Visnjic, D., Z. Kalajzic, D.W. Rowe, et al. 2004. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103: 3258-3264.
82. Adams, G.B., R.P. Martin, I.R. Alley, et al. 2007. Therapeutic targeting of a stem cell niche. Nat. Biotechnol. 25: 238-243.
83. Shiozawa, Y. & R.S. Taichman . 2012. Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche. Exp. Hematol. 40: 685-694.
84. Asada, N. & Y. Katayama . 2014. Regulation of hematopoiesis in endosteal microenvironments. Int. J. Hematol. 99: 679-684.
85. Kunisaki, Y., I. Bruns, C. Scheiermann, et al. 2013. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502: 637-643.
86. Ding, L., T.L. Saunders, G. Enikolopov, et al. 2012. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481: 457-462.
87. Ding, L. & S.J. Morrison . 2013. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495: 231-235.
88. Kumano, K., S. Chiba, A. Kunisato, et al. 2003. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 18: 699-711.
89. Schreck, C., F. Bock, S. Grziwok, et al. 2014. Regulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche. Ann. N. Y. Acad. Sci. 1310: 32-43.
90. Lo Celso, C. & D.T. Scadden . 2011. The haematopoietic stem cell niche at a glance. J. Cell. Sci. 124: 3529-3535.
91. Renstrom, J., M. Kroger, C. Peschel, et al. 2010. How the niche regulates hematopoietic stem cells. Chem. Biol. Interact. 184: 7-15.
92. Smith, J.N. & L.M. Calvi . 2013. Concise review: current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells. Stem Cells 31: 1044-1050.
93. Omatsu, Y., M. Seike, T. Sugiyama, et al. 2014. Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation. Nature 508: 536-540
94. Kieslinger, M., S. Hiechinger, G. Dobreva, et al. 2010. Early B cell factor 2 regulates hematopoietic stem cell homeostasis in a cell-nonautonomous manner. Cell Stem Cell 7: 496-507.
95. Lawrence, M.S., P. Stojanov, C.H. Mermel, et al. 2014. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505: 495-501.
96. Rupec, R.A., F. Jundt, B. Rebholz, et al. 2005. Stroma-mediated dysregulation of myelopoiesis in mice lacking IκBα. Immunity 22: 479-491.
97. Walkley, C.R., J.M. Shea, N.A. Sims, et al. 2007. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 129: 1081-1095.
98. Walkley, C.R., G.H. Olsen, S. Dworkin, et al. 2007. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129: 1097-1110.
99. Wang L., H. Zhang, S. Rodriguez, et al. 2014. Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NFκB-dependent manner. Cell Stem Cell 15: 51-65.
100. Parks, A.L., K.M. Klueg, J.R. Stout, et al. 2000. Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development 127: 1373-1385.
101. Koo, B.K., H.S. Lim, R. Song, et al. 2005. Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. Development 132: 3459-3470.
102. Koo, B.K., M.J. Yoon, K.J. Yoon, et al. 2007. An obligatory role of mind bomb-1 in notch signaling of mammalian development. PLoS One 2: e1221.
103. Kim, Y.W., B.K. Koo, H.W. Jeong, et al. 2008. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood 112: 4628-4638.
104. Kumar, M.S., J. Lu, K.L. Mercer, et al. 2007. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39: 673-677.
105. Raaijmakers, M.H., S. Mukherjee, S. Guo, et al. 2010. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464: 852-857.
106. Kode, A., J.S. Manavalan, I. Mosialou, et al. 2014. Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts. Nature 506: 240-244.
107. Schepers, K., E.M. Pietras, D. Reynaud, et al. 2013. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13: 285-299.
108. Colmone, A., M. Amorim, A.L. Pontier, et al. 2008. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322: 1861-1865.
109. Stier, S., Y. Ko, R. Forkert, et al. 2005. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201: 1781-1791.
110. Haylock, D.N. & S.K. Nilsson . 2006. Osteopontin: a bridge between bone and blood. Br. J. Haematol. 134: 467-474.
111. Boyerinas, B., M. Zafrir, A.E. Yesilkanal, et al. 2013. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy. Blood 121: 4821-4831.
112. Liersch, R., J. Gerss, C. Schliemann, et al. 2012. Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Blood 119: 5215-5220.
113. Zhang, B., Y.W. Ho, Q. Huang, et al. 2012. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer. Cell 21: 577-592.
114. Frisch, B.J., J.M. Ashton, L. Xing, et al. 2012. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood 119: 540-550.
115. Krause, D.S., K. Fulzele, A. Catic, et al. 2013. Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat. Med. 19: 1513-1517.
116. Geyh, S., S. Oz, R.P. Cadeddu, et al. 2013. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells. Leukemia 27: 1841-1851.
117. Varga, G., J. Kiss, J. Varkonyi, et al. 2007. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes. Pathol. Oncol. Res. 13: 311-319.
118. Sethi, N. & Y. Kang . 2011. Notch signalling in cancer progression and bone metastasis. Br. J. Cancer 105: 1805-1810.
119. Baccelli, I. & A. Trumpp . 2012. The evolving concept of cancer and metastasis stem cells. J. Cell Biol. 198: 281-293.
120. Olechnowicz, S.W. & C.M. Edwards . 2014. Contributions of the host microenvironment to cancer-induced bone disease. Cancer Res. 74: 1625-1631.
121. Ito, Y., T. Iwase & K. Hatake . 2012. Eradication of breast cancer cells in patients with distant metastasis: the finishing touches? Breast Cancer. 19: 206-211.
122. Esposito, M. & Y. Kang . 2014. Targeting tumor-stromal interactions in bone metastasis. Pharmacol. Ther. 141: 222-233.
123. Sethi, N. & Y. Kang . 2011. Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat. Rev. Cancer 11: 735-748.
124. Sethi, N., X. Dai, C.G. Winter, et al. 2011. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 19: 192-205.
125. Shiozawa, Y., E.A. Pedersen, A.M. Havens, et al. 2011. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J. Clin. Invest. 121: 1298-1312.
126. Méndez-Ferrer, S., T.V. Michurina, F. Ferraro, et al. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.